Related Experiment Video
Updated: Aug 13, 2026
10:39
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Effect of platinum compounds on murine lymphocyte mitogenesis
Japanese Journal of Medical Science & Biology
|April 1, 1979
Summary
Platinum compounds showed greater toxicity to T-lymphocyte function than to B-lymphocyte function in mice. This study investigated the impact of various platinum compounds on immune cell responses.
Area of Science:
- Immunology
- Pharmacology
- Toxicology
Background:
- Platinum-based compounds are widely used in cancer chemotherapy.
- Understanding their immunomodulatory effects is crucial for patient care.
- T-lymphocytes and B-lymphocytes play critical roles in adaptive immunity.
Purpose of the Study:
- To investigate the differential toxicity of four platinum compounds on murine T and B lymphocytes.
- To assess the impact of platinum compounds on lymphocyte function following intravenous administration.
Main Methods:
- Polyclonal activation of T and B lymphocytes using concanavalin A and lipopolysaccharide, respectively.
- Intravenous injection of cis-dichlorodiammine platinum, dichloro 1,2 benzenediamine N,N' platinum, cis-dichlorobis(cyclohexylamine) platinum, and cis-dichlorobis(cyclopentylamine) platinum.
- Analysis of T and B splenic lymphocyte function through single-dose time-course and dose-response studies.
Main Results:
- Platinum compounds exhibited greater toxicity towards T-lymphocyte function compared to B-lymphocyte function.
- Differential sensitivity of T and B lymphocytes to platinum-induced toxicity was observed.
- Dose-response relationships indicated a clear impact on lymphocyte viability and function.
Conclusions:
- The studied platinum compounds possess selective toxicity towards T-lymphocytes.
- These findings highlight the potential immunomodulatory side effects of platinum-based drugs.
- Further research is warranted to elucidate the mechanisms underlying this differential toxicity.
